ARTICLE | Company News
Texas Biotech, Synthélabo deal
July 1, 1996 7:00 AM UTC
Texas Biotechnology Corp. (TXB), Houston, Texas Synthélabo, Paris, France Synthélabo will obtain data from TXB's clinical trial for Novastan ( argatroban) as an adjunct to streptokinase therapy in ...